Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Advertising & Marketing

Sales

Legal & Regulatory

Acquisition & Integration

Goodwill impairment

Restructuring costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Teladoc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002, by George Byron Brooks and Gary Wald and is headquartered in Purchase, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Teladoc reports solid Q4 growth, eyes revenue optimization strategies

Teladoc's Q4 performance showed revenue growth and margin focus, with BetterHelp contributing significantly to profitability.
The company's strategic focus on virtual care expansion and revenue optimization positions Teladoc for continued success in the healthcare market.
While facing internal restructuring challenges, Teladoc's emphasis on growth drivers and operational efficiency presents opportunities for future growth and market leadership.

Teladoc Health excels in Q1, eyes growth and efficiency

Teladoc Health's Q1 performance was strong, with revenue exceeding expectations.
The company is focused on efficiency, innovation, and driving value in virtual care.
BetterHelp segment showed growth and stability, with improving margins expected.
Opportunities exist to capitalize on ad pricing stability and consumer behavior trends.

Teladoc surpasses revenue expectations, focuses on innovation and growth

Teladoc's Q2 performance exceeded expectations, with strong revenue growth and improved margins in both segments. The company's strategic focus on whole-person care, weight management, and AI enhancements positions it well for future growth. Challenges include managing drug costs and private company valuations, while opportunities lie in virtual care demand and strategic M&A.
Teladoc's financial strength, commitment to innovation, and focus on efficiency improvements are key strengths driving its performance. The company's ability to navigate challenges and capitalize on opportunities in the evolving healthcare landscape underscores its resilience and growth potential.

Teladoc Health surpasses Q3 expectations, eyes margin expansion in '24

Teladoc Health's Q3 performance exceeded expectations, driven by revenue growth and margin improvements.
The company is focused on enhancing cost efficiencies, profitability, and driving margin expansion.
Stable pricing environment and strong client demand present opportunities for future growth.
Operational review and strategic initiatives position Teladoc for continued success in the healthcare sector.

Teladoc reports robust 2023 earnings, eyes growth amid marketing challenges

Teladoc delivered strong financial performance in 2023 with notable growth in adjusted EBITDA and revenue. The company faces challenges in BetterHelp marketing yields and delayed consumer engagement efforts.
However, Teladoc's strategic strengths lie in its long-term outlook for revenue growth, margin expansion, and cost-saving initiatives. Opportunities exist in optimizing sales force structure and capital deployment for future growth.
Overall, Teladoc's focus on profitability, growth optimization, and strategic capital allocation positions it well for sustained success in the telehealth industry.

Teladoc Health reports solid Q1 performance amidst revenue challenges

Teladoc Health's Q1 2024 performance showcased revenue growth in Integrated Care but challenges in BetterHelp segment revenue and margin management.
The company's financial strength, product portfolio, and cost initiatives position it well for growth opportunities and strategic market positioning.
Addressing challenges in ad spend management and focusing on international market efficiency are key to unlocking growth potential and improving financial performance.
Overall, Teladoc's performance, strengths, challenges, and opportunities reflect a dynamic landscape with strategic focus on sustainable growth and operational efficiency.

Teladoc Health reports Q2 revenue dip, EBITDA growth; addresses challenges

Teladoc Health's Q2 2024 performance showed mixed results with revenue decline but EBITDA growth. The company is leveraging strengths in patient safety and technology while addressing challenges in customer acquisition costs. Opportunities lie in operational efficiency, insurance coverage access, and international expansion.

Teladoc Health reports Q3 revenue decline but strategic growth

Teladoc Health's Q3 2024 performance reflects mixed results with revenue decline but strategic growth in the Integrated Care segment.
The company's focus on customer-centric strategies, technology, and clinical excellence positions it well for future success and market leadership.
Challenges in revenue decline and expense management require Teladoc Health to balance short-term financial performance with long-term growth objectives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002, by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in Purchase, NY.

The company should still be a compelling growth stock after the coronavirus, when things go back to normal (we hope). But investors might not care.

Where Will Teladoc Be in 5 Years?

Livongo Health Inc

Shares of the health tech companies rose as the combined company announced its first sale.

Why Teladoc and Livongo Were Climbing Today

ABIOMED

Exelixis

Look for proven resilience and growth prospects on the horizon.

3 Safe Stocks for a Coming Market Crash

Apple

You can profit from several seeming unstoppable trends with these three stocks.

Only Have $500 to Invest? Buy These 3 Great Stocks

American Well Corporation

Access to healthcare in America has changed, and these two companies could help you benefit.

The Top 2 Telehealth Stocks to Buy in October

DocuSign

Take a new way to solve a problem, add a pinch of secular tailwinds and a dose of large addressable market, and you have all the ingredients for a multi-bagger investment.

Got $3,000? Buy These 3 Unstoppable Stocks With Multi-Bagger Potential

Chegg

Match Group

Time will reward investors' discipline if they resist the temptation to take profits from these holdings.

No Matter What Happens, Don't Panic-Sell These 3 Growth Stocks

Anthem

CVS Health

GoodRx Holdings

Humana

Remote and virtual medicine has taken off during the pandemic, and these telehealth stocks -- and their investors -- are reaping the rewards. The post 7 Telehealth Stocks Paving the Digital Medicine Landscape appeared first on InvestorPlace.

7 Telehealth Stocks Paving the Digital Medicine Landscape

Teladoc (TDOC) continues to benefit from increased telehealth visits and a strong balance sheet, which have been aiding its share price.

Teladoc (TDOC) Stock Soars 166% YTD: More Room for Upside?

CrowdStrike

Intuitive Surgical

Okta

Pinterest

Block

Velodyne Lidar

These innovative stocks are worth considering for investors who want to bet on the future without getting sucked into the mega-cap tech space. The post 7 Innovative Stocks Pushing Our World Ahead appeared first on InvestorPlace.

7 Innovative Stocks Pushing Our World Ahead

There's a new acronym in town, and these four innovative stocks can lead your portfolio to massive gains in the years to come.

Forget the FAANG Stocks and Buy "TIPS" Instead

TopBuild

Five Below

Generac Holdings

Landbridge Co LLC

Pool

Universal Forest Products

Sunrun

The top 10 ETFs for small-cap stocks have average total assets of $3.7 billion. Here are 10 recommendations from each of these ETFs.

10 Small-Cap Stocks to Buy From Some of America’s Best ETFs

Trade Desk

Buying shares of these leading innovators in fast-growing markets should deliver huge gains over the long run.

3 Unstoppable Stocks to Buy That Should Make You a Fortune

Palo Alto Networks

Growth and innovation will take precedence in what should be a multiyear bull market.

5 Must-Own Stocks for the New Bull Market

Amgen

Target

These healthcare and retail giants have proven their resilience during a rough-and-tumble year.

Market Crash 2.0: 3 Stocks to Save Your Portfolio

The company is using acquisitions to build a lead in virtual healthcare, but impressive competitors are laying the groundwork for future dominance.

Is Big Tech Putting Teladoc's Future in Jeopardy?

SALT LAKE CITY and SEATTLE, Oct. 1, 2020 /PRNewswire/ -- Qualtrics, the leader in customer experience and creator of the experience management category, today announced that Teladoc, the world leader in virtual care, has selected Qualtrics CustomerXM. "Telehealth has quickly become one of...

Teladoc Selects Qualtrics CustomerXM

Alibaba

Salesforce

Carvana

PayPal

Spotify

Spiros Segalas' Top 3rd-Quarter Trades

Telehealth stocks are in limelight as the coronavirus pandemic accelerates adoption of telehealth services. Robust industry growth likely in the coming years.

3 Telehealth Stocks Ready for Flu Season

These high-growth industry leaders may be unstoppable.

Got $5,000? 3 Explosive Growth Stocks to Buy Now

Abbott Labs

Pfizer

These stocks are perfectly positioned if the COVID-19 pandemic worsens in the U.S.

A Second Wave of Coronavirus Could Be Coming: 3 Stocks to Buy Before It Hits

Peloton

Shopify

Zoom Video

Friday gave investors a nice end to the week.

Stay-at-Home Stocks Send Markets Soaring Friday

Just days after its IPO, GoodRx already has a valuation that rivals that of Teladoc Health. Can the fast-growing upstart leverage its popularity to become the new king of virtual healthcare?

Should Teladoc Be Worried About GoodRx?

Innovative Industrial Properties

They're making big differences in their respective markets and providing big gains for investors.

Got $3,000? 3 Game-Changing Stocks to Buy Right Now

There's a possibility we may not get a coronavirus vaccine through clinical trials. Here are three stocks to buy in case that happens.

News for Teladoc Stock (TDOC)